Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Preoperative and operative factors to predict incontinence, impotence and stricture after radical prostatectomy.

Publication ,  Journal Article
Moul, JW; Mooneyhan, RM; Kao, T-C; McLeod, DG; Cruess, DF
Published in: Prostate Cancer Prostatic Dis
September 1998

The purpose of this study was to determine the incidence of patient-self reported post prostatectomy incontinence, impotence, bladder neck contracture or stricture, better, same or worse quality of life and willingness for same treatment again in a large group of radical prostatectomy (RP) patients and to determine if these morbidities are predictable with demographic, surgical or prostate cancer (PC) factors. Methods: A patient self-reporting questionnaire was completed and returned by 374 out of 458 eligible (81.7%) RP patients from one center, 267 (72.2%) have been operated since 1990 and all of whom were a minimum six month postoperative (75%>1 y). Questionnaire results were independently analyzed by a third party and correlated to demographic, operative, and tumor factors in an ongoing comprehensive PC database. Results: The patient self-reported incidence of post prostatectomy incontinence (any degree), impotence, and bladder neck contracture or stricture was 72.2, 87.4, and 25.9%, respectively. The reported rate of incontinence requiring protection was 39.0% and only 2.4% had persistent bladder neck contracture/stricture. Pathologic stage (continuous variable) was the only factor to significantly predict incontinence and no factor could predict impotence or bladder neck contracture/stricture in univariate analysis. No factor was predictive of morbidity by multivariate analysis. Despite incontinence and impotence significantly affecting QOL self-reporting (P=0.001, 0.001, respectively) and willingness to undergo RP again (P=0.001, 0.067, respectively), the majority of patients would choose surgery again. Conclusions: Although radical prostatectomy morbidity is common and affects patient-reported overall QOL, most patients would choose the same treatment again. Demographic, preoperative, operative, and tumor factors did not reliably predict patient-reported morbidity in this series.

Duke Scholars

Published In

Prostate Cancer Prostatic Dis

DOI

EISSN

1476-5608

Publication Date

September 1998

Volume

1

Issue

5

Start / End Page

242 / 249

Location

England

Related Subject Headings

  • Urology & Nephrology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Moul, J. W., Mooneyhan, R. M., Kao, T.-C., McLeod, D. G., & Cruess, D. F. (1998). Preoperative and operative factors to predict incontinence, impotence and stricture after radical prostatectomy. Prostate Cancer Prostatic Dis, 1(5), 242–249. https://doi.org/10.1038/sj.pcan.4500248
Moul, J. W., R. M. Mooneyhan, T. -. C. Kao, D. G. McLeod, and D. F. Cruess. “Preoperative and operative factors to predict incontinence, impotence and stricture after radical prostatectomy.Prostate Cancer Prostatic Dis 1, no. 5 (September 1998): 242–49. https://doi.org/10.1038/sj.pcan.4500248.
Moul JW, Mooneyhan RM, Kao T-C, McLeod DG, Cruess DF. Preoperative and operative factors to predict incontinence, impotence and stricture after radical prostatectomy. Prostate Cancer Prostatic Dis. 1998 Sep;1(5):242–9.
Moul, J. W., et al. “Preoperative and operative factors to predict incontinence, impotence and stricture after radical prostatectomy.Prostate Cancer Prostatic Dis, vol. 1, no. 5, Sept. 1998, pp. 242–49. Pubmed, doi:10.1038/sj.pcan.4500248.
Moul JW, Mooneyhan RM, Kao T-C, McLeod DG, Cruess DF. Preoperative and operative factors to predict incontinence, impotence and stricture after radical prostatectomy. Prostate Cancer Prostatic Dis. 1998 Sep;1(5):242–249.

Published In

Prostate Cancer Prostatic Dis

DOI

EISSN

1476-5608

Publication Date

September 1998

Volume

1

Issue

5

Start / End Page

242 / 249

Location

England

Related Subject Headings

  • Urology & Nephrology
  • 1112 Oncology and Carcinogenesis